Aclipse Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Aclipse Therapeutics's estimated annual revenue is currently $804k per year.
- Aclipse Therapeutics's estimated revenue per employee is $100,500
- Aclipse Therapeutics's total funding is $4.1M.
Employee Data
- Aclipse Therapeutics has 8 Employees.
- Aclipse Therapeutics grew their employee count by 33% last year.
Aclipse Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | VP, Corporate Development and Finance | Reveal Email/Phone |
3 | Chief Scientific Officer and Co-founder | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
Aclipse Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Aclipse Therapeutics?
Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.
keywords:N/A$4.1M
Total Funding
8
Number of Employees
$804k
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.6M | 46 | 5% | N/A |
#2 | $6.9M | 64 | -19% | N/A |
#3 | $31.4M | 175 | -4% | N/A |